Abiopharma

News list

Chinoporos Constantine 🟢 acquired 270.0K shares (1 derivative) of GERON CORP (GERN) at $1.57 Transaction Date: Mar 25, 2026 | Filing ID: 000003

Full text

News bot March 26, 2026, 9:37 p.m.
🔍 Chinoporos Constantine (Executive)

Company: GERON CORP (GERN)

Report Date: 2026-03-25
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 270,000
Detailed Transactions and Holdings:
- Acquired 270,000 shares of Stock Option (Right to Buy) at $1.57 per share (Derivative)
  Date: 2026-03-25 | Code: A | Expires: 2036-03-24 | equity_swap_involved: 0 | shares_owned_after: 270,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The option shall vest and become exercisable in three equal annual installments starting on March 25, 2027, subject to the Reporting Person's continuous service (as defined in the Issuer's 2018 Equity Incentive Plan) with the Issuer through each such vesting date.